History

Xendo offers a wide variety of services and has been in business for more than 20 years. Our company's history is briefly outlined below.

2011
Xendo BV and Batavia Bioservices BV have initiated a strategic business collaboration. As a consequence, all Bioprocess activities of Xendo Manufacturing BV have been transferred to Batavia Bioservices BV. Through this collaboration Xendo can continue to offer Bioprocessing services.

2010
As per July 2010 Xendo Drug Development has been acquired by QPS  (an international CRO). The Xendo consultancy and manufacturing activities continue under the name  Xendo.

2009
The Leiden site realigns its structure to better serve our customers. Three divisions were formed, creating a maximal synergy:

Xendo establishes Xendo Deutschland in Berlin, to better meet the needs of German customers. Focus of the German services are on regulatory affairs for drugs and medical devices, from initial set-up to maintenance of dossiers. 

2008
The Groningen site expands its clinical research portfolio offering (temporary) contract research services in support of phase II – IV studies with drug and medical device candidates. These services are offered through a new division named Xendo Clinical Research.

2007
Xendo B.V. forms a joint venture with the University Medical Center Groningen. The joint venture, Xendo Clinical Trial Material, will produce drug candidates on small scale according to Good Manufacturing Practices.

2006
Xendo B.V. further expands in Scandinavia by founding ‘Xendo Pharma Services A/S’, a subsidiary based in the area of greater Copenhagen, Denmark.

As of January 1st, 2006, Univalid Holding B.V. has been restructurered and renamed Xendo B.V. Xendo employs close to 200 people and is comprised of three operational divisions:

• Xendo Drug Development B.V.
• Xendo Manufacturing B.V.
• Xendo Pharma Services B.V.

2005
Xendo Clinics B.V. opens a second 14-bed Clinical Pharmacology Unit for phase I/IIa clinical research on the premises of the University Medical Centre Groningen.

2004
Xendo Drug Development B.V. expands with Xendo Clinics B.V., a 12-bed Clinical Pharmacology Unit for phase I/IIa clinical research, and Xendo Pharma Design B.V., a consultancy firm focusing on strategic drug research and development, both on the premises of the University Medical Centre Groningen.

Xendo Drug Development B.V., a 100% subsidiary of Univalid Holding B.V., is founded in Groningen, to hold Xendo Laboratories B.V.

Quality Engineering, a business unit of Univalid Engineering B.V. internally merges with Univalid Metrology B.V. to form Univalid Technical Support B.V.

Univalid Bioprocessing B.V. moves its research and pilot laboratories from Delft University to the Bio Science Park in Leiden.

2002
Univalid Holding B.V. acquires a part of Bird Engineering B.V. to form Univalid Bioprocessing B.V.

2001
Univalid opens a branch office in Sweden: Univalid Compliance and Validation AB, under Univalid Scandinavia AB.

2000
The company headquarters move from Amsterdam to the Bio Science Park Leiden.

Univalid Holding B.V. becomes the umbrella company over all operating companies. The names of the different operating companies in Leiden are uniformed:

• Eurovalid-Arthemius B.V. changes to Univalid Compliance and Validation B.V.
• Helix Engineering B.V. changes to Univalid Engineering B.V.
• Probion B.V. changes to Univalid Management and Development B.V.
• Vipquip B.V. changes to Univalid Metrology B.V.

Xendo Laboratories B.V. although part of Univalid Holding B.V. keeps its name.

1999
Xendo Laboratories B.V., a bioanalytical contract laboratory is founded in Groningen.

1998
Helix Engineering B.V. starts collaboration with Eurovalid-Arthemius B.V. to expand the range of services with pharmaceutical engineering.

New activities are employed by starting VipQuip B.V., offering services on metrology and calibration.

Probion B.V., delivering management and business development services to the (bio)pharmaceutical industries, teams up.

1997
Eurovalid B.V. and Arthemius v.o.f. internally merge to form Eurovalid-Arthemius B.V.

1996
Arthemius v.o.f. was founded, to bring additional expertise for the biotechnology sector.

1995
Eurovalid is incorporated into Eurovalid B.V.

1990
Eurovalid is founded in Amsterdam, providing compliance and validation services to the pharmaceutical industry.